Utku S - Search Results

1

Cryptographically supported NFC tags in medication for better inpatient safety.

Özcanhan MH, Dalkılıç G, Utku S. Özcanhan MH, et al. Among authors: utku s. J Med Syst. 2014 Aug;38(8):61. doi: 10.1007/s10916-014-0061-x. Epub 2014 Jun 24. J Med Syst. 2014. PMID: 24957387

2

Automated personnel-assets-consumables-drug tracking in ambulance services for more effective and efficient medical emergency interventions.

Utku S, Özcanhan MH, Unluturk MS. Utku S, et al. Comput Methods Programs Biomed. 2016 Apr;127:216-31. doi: 10.1016/j.cmpb.2015.12.019. Epub 2016 Jan 2. Comput Methods Programs Biomed. 2016. PMID: 26777434

3

A robotic system to prepare IV solutions.

Unluturk MS, Tamer O, Utku S. Unluturk MS, et al. Among authors: utku s. Int J Med Inform. 2018 Nov;119:61-69. doi: 10.1016/j.ijmedinf.2018.09.011. Epub 2018 Sep 11. Int J Med Inform. 2018. PMID: 30342687

4

Spine Surgery Database: Spine Disease Analytical Evaluation Module.

Utku S. Utku S. Turk Neurosurg. 2021;31(2):182-188. doi: 10.5137/1019-5149.JTN.28328-19.1. Turk Neurosurg. 2021. PMID: 33216338 Free article.

5

Spine surgery database: a Turkish registry for spinal disorders.

Utku S, Baysal H, Zileli M. Utku S, et al. Turk Neurosurg. 2010 Apr;20(2):223-30. doi: 10.5137/1019-5149.JTN.2538-09.1. Turk Neurosurg. 2010. PMID: 20401850 Free article.

6

Synthesis and biological evaluation of new 3(2H)-pyridazinone derivatives as non-toxic anti-proliferative compounds against human colon carcinoma HCT116 cells.

Özdemir Z, Utku S, Mathew B, Carradori S, Orlando G, Di Simone S, Alagöz MA, Özçelik AB, Uysal M, Ferrante C. Özdemir Z, et al. Among authors: utku s. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1100-1109. doi: 10.1080/14756366.2020.1755670. J Enzyme Inhib Med Chem. 2020. PMID: 32321320 Free PMC article.

7

A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies.

Özçelik AB, Özdemir Z, Sari S, Utku S, Uysal M. Özçelik AB, et al. Among authors: utku s. Pharmacol Rep. 2019 Dec;71(6):1253-1263. doi: 10.1016/j.pharep.2019.07.006. Epub 2019 Jul 22. Pharmacol Rep. 2019. PMID: 31675671

8

Synthesis, in-vitro cytotoxic activity and DNA interactions of new dicarboxylatoplatinum(II) complexes with 2-hydroxymethylbenzimidazole as carrier ligands.

Utku S, Ozçelik AB, Gümüş F, Yılmaz S, Arsoy T, Açık L, Celebi Keskin A. Utku S, et al. J Pharm Pharmacol. 2014 Nov;66(11):1593-605. doi: 10.1111/jphp.12290. Epub 2014 Aug 11. J Pharm Pharmacol. 2014. PMID: 25109360

9

Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands.

Ozçelik AB, Utku S, Gümüş F, Keskin AÇ, Açık L, Yılmaz S, Ozgüngör A. Ozçelik AB, et al. Among authors: utku s. J Enzyme Inhib Med Chem. 2012 Jun;27(3):413-8. doi: 10.3109/14756366.2011.594046. Epub 2012 Feb 3. J Enzyme Inhib Med Chem. 2012. PMID: 22299582

10

Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.

Utku S, Gökçe M, Orhan I, Sahin MF. Utku S, et al. Arzneimittelforschung. 2011;61(1):1-7. doi: 10.1055/s-0031-1296161. Arzneimittelforschung. 2011. PMID: 21355440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page